Pediatrix Medical Group (MD) to Release Quarterly Earnings on Tuesday

Pediatrix Medical Group (NYSE:MD) is scheduled to be issuing its quarterly earnings data before the market opens on Tuesday, May 7th. Analysts expect the company to announce earnings of $0.15 per share for the quarter. Persons interested in participating in the company’s earnings conference call can do so using this link.

Pediatrix Medical Group (NYSE:MD) last issued its quarterly earnings results on Tuesday, February 20th. The company reported $0.32 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.30 by $0.02. The business had revenue of $496.44 million for the quarter, compared to analyst estimates of $524.30 million. Pediatrix Medical Group had a negative net margin of 3.03% and a positive return on equity of 10.35%. The business’s revenue was down 3.4% compared to the same quarter last year. During the same period in the previous year, the business posted $0.46 earnings per share. On average, analysts expect Pediatrix Medical Group to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Pediatrix Medical Group Price Performance

Shares of MD stock opened at $9.33 on Monday. The company has a debt-to-equity ratio of 0.73, a current ratio of 1.24 and a quick ratio of 1.24. The stock has a 50 day simple moving average of $9.23 and a 200-day simple moving average of $9.45. Pediatrix Medical Group has a 12-month low of $7.70 and a 12-month high of $15.02.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on MD shares. Jefferies Financial Group reduced their target price on Pediatrix Medical Group from $10.00 to $9.00 and set a “hold” rating for the company in a report on Wednesday, March 6th. TheStreet lowered shares of Pediatrix Medical Group from a “c” rating to a “d” rating in a research report on Friday, February 23rd. Truist Financial reduced their price target on shares of Pediatrix Medical Group from $10.50 to $10.00 and set a “hold” rating for the company in a research report on Wednesday, February 21st. Finally, Mizuho lowered their price target on Pediatrix Medical Group from $10.00 to $9.00 and set a “neutral” rating on the stock in a report on Wednesday, February 21st. Five research analysts have rated the stock with a hold rating, Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $9.38.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.